Additional hemoperfusion is associated with improved overall survival and self-reported sleep disturbance in patients on hemodialysis.
In this study, we attempted to explore whether long-term hemoperfusion could improve sleep and increase the overall survival in hemodialysis patients.
METHODS:: A total of 158 patients, who underwent routine hemodialysis, were assessed in this study. These patients were computer-matched into two groups, with one group including 80 patients with absolute hemodialysis and the other consisting of 78 cases with hemodialysis in combination with hemoperfusion. Hemoperfusion was performed 1-2 times biweekly, with each session lasting 2 h. Self-reported sleep disturbance was evaluated before and after the observational time (2-year period); sleep quality was measured using the Pittsburgh Sleep Quality Index.
FINDINGS:: Using multivariate regression analyses, we found sleep duration was associated with age, diabetes, low income, pruritus, hyperphosphatemia, hypercalcemia, high parathyroid hormone, and hemoglobin ( P < 0.001). The overall survival rate of the hemodialysis in combination with hemoperfusion group was significantly higher than that of the absolute hemodialysis group ( P < 0.05) after adjusting for sex, age, and diabetes. A 2-year hemoperfusion therapy was associated with improved sleep disturbance and sleep efficiency; this was accompanied by an increase in nocturnal melatonin levels. Furthermore, there was a significant difference in the first hospitalization between the hemodialysis and hemodialysis in combination with hemoperfusion group...
Source: The International Journal of Artificial Organs - Category: Transplant Surgery Authors: Gu YH, Yang XH, Pan LH, Zhan XL, Guo LL, Jin HM Tags: Int J Artif Organs Source Type: research
More News: Computers | Diabetes | Dialysis | Endocrinology | Hemodialysis | Hormones | Melatonin | Sleep Disorders | Sleep Medicine | Study | Transplant Surgery